Kanyini Vascular Collaboration

Menu:

The primary goal of the audit is to measure evidence- practice gaps in the identification and management of vascular risk.

The Kanyini Vascular Audit

Background

Two boys laughingCardiovascular disease (CVD) is the leading cause of premature death and disability in Australia. Aboriginal and Torres Strait Islander people are disproportionately affected by this burden and CVD is the main reason for the widening gap in life expectancy between Indigenous and non-Indigenous people.

There is now a substantial body of evidence showing that CVD risk factors interact synergistically and that no one risk factor should be managed in isolation. Integrated global risk assessment approaches are almost universally recommended in national and international guidelines.

Despite these guidelines, evidence-practice gaps are wide. The complexities of identifying people at high risk and making practical links to guideline-based care are probably significant contributors to treatment gaps.

Goal

The primary goal of the Kanyini Vascular Audit is to quantify the magnitude of evidence-practice gaps in the identification and management of vascular risk among Aboriginal and Torres Strait Islander people.

Objectives

The specific objectives of this study are to:

Study Design

Review of records

The Vascular Audit will involve a retrospective review of primary care records of a random selection of 1200 regular attendees from participating Aboriginal Medical Services.

This study aims to review at least 200 Aboriginal and Torres Strait Islander adult case records (aged 18 years and over) from each site. It will describe:

Where risk is identified, treatment gaps will be measured against a range of guidelines.

The uptake of the Adult Health Check will also be assessed along with the adequacy of risk assessments performed in those adults who have received this check.

Systems level audit

The review will be complemented by a Systems Level Audit which will focus on:

If feasible, a model will be built to analyse system level correlates and adherence to treatment guidelines.

Scientific and Operation Advisory Committees

A clinical governance group comprising representatives of the study investigators and local study site co-investigators will be established to oversee the development of the audit tools, administration, data feedback strategies and implementation of performance monitoring frameworks.

Health service staff and local advisory committees will participate in finalising the audit methodology and structure. Where feasible, Indigenous Research Fellows will be trained and supported to conduct data collection, analysis and feedback to the participating health services. These audits will inform quality frameworks within participating health services.

Expected Outcomes